Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity.
Kohrt HE, Sagiv-Barfi I, Rafiq S, Herman SE, Butchar JP, Cheney C, Zhang X, Buggy JJ, Muthusamy N, Levy R, Johnson AJ, Byrd JC.
Kohrt HE, et al. Among authors: levy r.
Blood. 2014 Mar 20;123(12):1957-60. doi: 10.1182/blood-2014-01-547869.
Blood. 2014.
PMID: 24652965
Free PMC article.
No abstract available.